key: cord-0993874-tpnrmj4r authors: van Rijn, Cees; Somsen, G. Aernout; Hofstra, Leonard; Dahhan, Ghassan; Bem, Reinout A.; Kooij, Stefan; Bonn, Daniel title: Reducing aerosol transmission of SARS‐CoV‐2 in hospital elevators date: 2020-09-23 journal: Indoor Air DOI: 10.1111/ina.12744 sha: 3f422887ef56fc38fde392ad7ff9b98c8dc3d511 doc_id: 993874 cord_uid: tpnrmj4r nan There is a worldwide discussion on the role of aerosols in the To investigate aerosol persistence in elevators, we mimic a single cough using a specially designed spray nozzle to disperse a controlled quantity of glycerol/ethanol droplets, that after evaporation of the ethanol have the same size distribution as evaporated respiratory droplets from a single cough. 5 SARS-CoV-2-infected sputum droplets from hospitalized but generally mildly ill people may carry between 10 4 and 10 9 RNA copies per mL. 6 A value of 10 9 implies roughly one virus particle per aerosol droplet with a radius of 5 µm; loud speaking may produce up to a few hundred thousand droplets per minute, 7-9 whereas a single cough can already produce a few million droplets. 10 World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief Airborne spread of SARS-CoV-2 and a potential role for air disinfection Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Evidence of airborne transmission of the severe acute respiratory syndrome virus Small droplet aerosols in poorly ventilated spaces; the need for specific measures to prevent SARS-CoV-2 transmission Virological assessment of hospitalized patients with COVID-2019 Quantity, size distribution, and characteristics of cough-generated aerosol produced by patients with an upper respiratory tract infection The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission Aerosol emission and superemission during human speech increase with voice loudness Estimation of viral aerosol emissions from simulated individuals with asymptomatic to moderate coronavirus disease 2019